Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults

StatusNot Yet Recruiting
PhasePhase 2/3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 78 → 83 locations
    • Eligibility criteria expanded, about 16 words
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare the efficacy and safety of BR005-036C versus placebo in subjects with Acute Migraines
Trial Details
NCT Number NCT07792681
Lead Sponsor Brise Pharmaceuticals Co., Ltd.
Conditions
(from sponsor)		 Migraine, With or Without Aura
Related terms Migraine Disorders
Enrollment 2,079 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov